© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...

The Jay baseball team has a couple new additions to its facility after an impressive season a year ago. Every time they walk into their fieldhouse, the Royals see a giant, blue “2024” toward ...

Scholar Rock (NASDAQ:SRRK) CEO Jay Backstrom said that there is a noticeable interest in preservation of lean muscle mass in weight loss therapies and the U.S. FDA has noted this. He believes that ...

Celgene has today confirmed that it will acquire Juno Therapeutics for $9 billion, and says the move will make it a leader in cell immunotherapy. The price is a significant premium on the $5.5 bn ...

Celgene's European leader Tuomo Pätsi talks to pharmaphorum about the firm's remarkable growth, which is set to continue thanks to myeloma blockbuster Revlimid and new psoriasis and psoriatic ...